U.S. flag

An official website of the United States government

NM_000388.4(CASR):c.130G>A (p.Val44Ile) AND Nephrolithiasis/nephrocalcinosis

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 22, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004036766.1

Allele description [Variation Report for NM_000388.4(CASR):c.130G>A (p.Val44Ile)]

NM_000388.4(CASR):c.130G>A (p.Val44Ile)

Gene:
CASR:calcium sensing receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q21.1
Genomic location:
Preferred name:
NM_000388.4(CASR):c.130G>A (p.Val44Ile)
HGVS:
  • NC_000003.12:g.122254319G>A
  • NG_009058.2:g.75652G>A
  • NM_000388.4:c.130G>AMANE SELECT
  • NM_001178065.2:c.130G>A
  • NP_000379.3:p.Val44Ile
  • NP_001171536.2:p.Val44Ile
  • NC_000003.11:g.121973166G>A
  • NG_009058.1:g.75637G>A
  • NM_000388.3:c.130G>A
  • NM_000388.4:c.130G>A
Protein change:
V44I
Links:
dbSNP: rs2074530467
NCBI 1000 Genomes Browser:
rs2074530467
Molecular consequence:
  • NM_000388.4:c.130G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178065.2:c.130G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Nephrolithiasis/nephrocalcinosis
Identifiers:
MedGen: CN580796

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002693806Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)		Uncertain significance
(Feb 22, 2022) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002693806.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.V44I variant (also known as c.130G>A), located in coding exon 1 of the CASR gene, results from a G to A substitution at nucleotide position 130. The valine at codon 44 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024